All posts tagged "Bladder Cancer;Immunotherapy;Clinical Trial;ASCO;ASCO GU;The Tisch Cancer Institute;Mount Sinai Health System"

Immunotherapy After Surgery Provides Significant, Durable Benefit for High-Risk Bladder Patients

[ad_1] Newswise — New York, NY (February 17, 2023)—Immunotherapy after surgery increased bladder cancer patients’ chance of staying cancer-free compared to patients who received a placebo,...